Fuji Seiki Co.,Ltd. (TYO:6400)
Japan · Delayed Price · Currency is JPY 285.00
+1.00 (0.35%)
Aug 14, 2025, 3:30 PM JST
Achilles Therapeutics Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 313 | 394 | 474 | 692 | 137 | Upgrade |
Depreciation & Amortization | 613 | 581 | 576 | 542 | 492 | Upgrade |
Loss (Gain) From Sale of Assets | 74 | 2 | 2 | -77 | 4 | Upgrade |
Other Operating Activities | -162 | -132 | -193 | -68 | -62 | Upgrade |
Change in Accounts Receivable | -49 | 211 | -277 | -78 | -16 | Upgrade |
Change in Inventory | -101 | 277 | 94 | -100 | -107 | Upgrade |
Change in Accounts Payable | 7 | -265 | -43 | 350 | -222 | Upgrade |
Change in Other Net Operating Assets | 160 | 29 | -40 | -375 | 462 | Upgrade |
Operating Cash Flow | 855 | 1,097 | 593 | 886 | 688 | Upgrade |
Operating Cash Flow Growth | -22.06% | 84.99% | -33.07% | 28.78% | -5.37% | Upgrade |
Capital Expenditures | -667 | -452 | -445 | -498 | -726 | Upgrade |
Sale of Property, Plant & Equipment | 12 | 1 | 36 | 89 | 2 | Upgrade |
Sale (Purchase) of Intangibles | -19 | -63 | -26 | -14 | -3 | Upgrade |
Investment in Securities | 1 | - | -1 | 3 | -57 | Upgrade |
Other Investing Activities | 56 | -3 | -6 | -2 | - | Upgrade |
Investing Cash Flow | -617 | -517 | -442 | -422 | -784 | Upgrade |
Short-Term Debt Issued | - | - | 60 | 10 | 320 | Upgrade |
Long-Term Debt Issued | 787 | 200 | 1,180 | 405 | 360 | Upgrade |
Total Debt Issued | 787 | 200 | 1,240 | 415 | 680 | Upgrade |
Short-Term Debt Repaid | -118 | -25 | - | - | - | Upgrade |
Long-Term Debt Repaid | -545 | -418 | -1,214 | -437 | -394 | Upgrade |
Total Debt Repaid | -663 | -443 | -1,214 | -437 | -394 | Upgrade |
Net Debt Issued (Repaid) | 124 | -243 | 26 | -22 | 286 | Upgrade |
Issuance of Common Stock | - | - | 6 | 2 | 9 | Upgrade |
Dividends Paid | -51 | -51 | -71 | -35 | -35 | Upgrade |
Other Financing Activities | -92 | -110 | -151 | -320 | -5 | Upgrade |
Financing Cash Flow | -19 | -404 | -190 | -375 | 255 | Upgrade |
Foreign Exchange Rate Adjustments | 77 | 46 | 79 | 51 | -22 | Upgrade |
Net Cash Flow | 296 | 222 | 40 | 140 | 137 | Upgrade |
Free Cash Flow | 188 | 645 | 148 | 388 | -38 | Upgrade |
Free Cash Flow Growth | -70.85% | 335.81% | -61.86% | - | - | Upgrade |
Free Cash Flow Margin | 2.28% | 7.81% | 1.89% | 5.20% | -0.64% | Upgrade |
Free Cash Flow Per Share | 23.21 | 79.58 | 18.38 | 48.52 | -4.77 | Upgrade |
Cash Interest Paid | 40 | 41 | 43 | 51 | 50 | Upgrade |
Cash Income Tax Paid | 164 | 138 | 177 | 69 | 60 | Upgrade |
Levered Free Cash Flow | 217.13 | 523.63 | -114 | 284.25 | -174.38 | Upgrade |
Unlevered Free Cash Flow | 242.13 | 548.63 | -87.13 | 316.13 | -143.13 | Upgrade |
Change in Working Capital | 17 | 252 | -266 | -203 | 117 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.